中国铀业 20260226 摘要 中国铀业 2024 年天然铀总产量接近 4,000 吨铀，境外自产量约 2,200 吨铀，国内产量约 1,700 吨铀，占全球总产量约 6.4%，资源端优势显 著，拥有国内外多处矿产资源。 公司业务核心为自产天然铀，毛利占比超六成，放射性共伴生矿产资源 综合利用为附属板块，聚焦独居石、铀钼与钽铌等品类，各自产出氯化 稀土、四钼酸铵、五氧化二钽与五氧化二铌等产品。 随着"国铀 1 号"木头项目建成，预计公司权益量将增加约 1,500 吨， 总权益量达到约 4,500 吨左右，预计 2027 年铀矿自产量将实现翻倍， 该项目建设周期预计较招股书缩短。 需求端受益于中国机组落地、美国核电投资及日本重启核电，需求增速 预计 4%-5%；供给端受资本开支不足影响，新增量主要来自老矿复产， 供需矛盾推动铀价上涨，短期目标价位 106 美元/磅，长期看涨至历史 高点 136 美元/磅。 公司 2025 年上半年营收 96 亿元，净利 7.6 亿元；预计全年净利将近 17 亿元。天然铀产品销售收入占比 65%，毛利占比 84%。放射性共伴 生矿产资源综合利用业务营收占比 6.6%，毛利占比 ...

Core Viewpoint - The nuclear power sector is gaining renewed attention from policymakers and capital markets due to its zero carbon emissions, high energy density, and stable output, with natural uranium's strategic importance becoming increasingly prominent in this context [2] Company Overview - China Uranium Corporation (stock code: 001280) holds a dominant position in the domestic natural uranium sector and has a leading global resource management capability, making it a key player in the natural uranium industry [2][3] - The company focuses on the mining, sales, and international trade of natural uranium while also expanding the comprehensive utilization of radioactive co-mined mineral resources [3] Financial Performance - In 2024, the company achieved a revenue of 17.28 billion yuan, a year-on-year increase of 16.7%, with a net profit attributable to shareholders of 1.46 billion yuan, up 15.6% [3] - Natural uranium sales contributed 83.6% of the company's gross profit, with the breakdown of natural uranium business including self-produced sales, purchased uranium sales, and international trade [3] Resource Advantage - The company possesses 17 mining rights for uranium or uranium-molybdenum mines in China, effectively monopolizing domestic natural uranium production [4] - In 2024, the domestic uranium production was approximately 1,700 tons of metal uranium, predominantly led by the company [4] - The company operates the Rossing uranium mine in Namibia, which has a design capacity of 4,500 tons of U₃O₈ per year, contributing approximately 280 million yuan to net profit in 2024 [4] Strategic Initiatives - The company successfully raised 4.36 billion yuan through its IPO, with significant investments directed towards natural uranium capacity expansion and the comprehensive utilization of co-mined resources [5] - The implementation of these projects is expected to enhance the efficiency and scale of uranium resource development, reducing reliance on purchased uranium [5] Market Dynamics - The natural uranium market is undergoing a fundamental shift in supply and demand, with global nuclear power construction accelerating [7] - The price of uranium has entered a new upward cycle, with spot prices exceeding $100 per pound and stabilizing around $86 per pound [7] Governance and Stability - The company has a robust governance structure backed by strong state-owned enterprise platforms, with a stable shareholding structure [8] - Long-term supply relationships with key clients ensure operational certainty and risk resilience [8] Future Outlook - With capacity release, resource efficiency improvements, and the expansion of co-mined business, the company is positioned to enhance profitability and market share while ensuring national energy security [9]

Investment Rating - The report assigns an "Outperform" rating for the company [4] Core Views - The company is a subsidiary of China National Nuclear Corporation, focusing on the comprehensive utilization of natural uranium and radioactive associated mineral resources [1][12] - The company plans to raise 4.4 billion yuan through its IPO, with 2.2 billion yuan allocated for natural uranium capacity projects and 700 million yuan for the comprehensive utilization of radioactive associated mineral resources [22] - The company is expected to produce 2,659 tons of U3O8 (equivalent to 2,255 tons of metal) from overseas sources in 2024, with an estimated domestic production of 1,700 tons, totaling 3,955 tons, which represents 6.4% of the global production of approximately 61,615 tons in 2024 [1][12] Summary by Sections Natural Uranium Business - The company has a dominant position in domestic natural uranium production, holding 17 mining rights for domestic natural uranium or uranium-molybdenum mines [1][59] - The natural uranium business is divided into self-produced uranium product sales, purchased uranium product sales, and international uranium trade [1][38] - The demand for natural uranium is expected to grow steadily, with supply constraints leading to a long-term bullish price outlook [1][39] Comprehensive Utilization of Radioactive Associated Mineral Resources - The company focuses on the comprehensive utilization of monazite, uranium-molybdenum, and tantalum-niobium [2] - The comprehensive utilization of monazite produces rare earth chlorides and sodium phosphate/carbonate as by-products, while uranium-molybdenum and tantalum-niobium processing yield ammonium paratungstate and tantalum/niobium oxides, respectively [2][27] Financial Forecast and Valuation - The company is projected to achieve net profits of 1.66 billion yuan, 3.49 billion yuan, and 4.87 billion yuan for the years 2025, 2026, and 2027, respectively, representing growth rates of 14%, 110%, and 40% [3][4] - The estimated reasonable valuation for the company is between 108.3 and 120.9 yuan, indicating a premium of 17% to 31% over the current stock price of 92.59 yuan [4]

Investment Rating - The report initiates coverage with a "Buy" rating and sets a target price of 80 CNY [5][11][15]. Core Insights - China Uranium Industry (001280) derives over 90% of its revenue from natural uranium business and is the exclusive supplier of natural uranium products for its controlling shareholder, China National Nuclear Corporation (CNNC) [2][11]. - The company is expected to benefit from the growing demand for nuclear energy and the ongoing global uranium supply-demand gap, which is projected to persist in the long term [11][39]. Financial Summary - The total revenue is projected to grow from 14,801 million CNY in 2023 to 31,422 million CNY by 2027, reflecting a compound annual growth rate (CAGR) of approximately 21.5% [4][16]. - Net profit attributable to the parent company is expected to increase from 1,262 million CNY in 2023 to 4,428 million CNY in 2027, with a significant growth rate of 87.8% in 2026 [4][11]. - Earnings per share (EPS) is forecasted to rise from 0.61 CNY in 2023 to 2.14 CNY in 2027 [4][11]. Revenue Breakdown - The revenue from natural uranium sales is expected to grow from 13,234.90 million CNY in 2023 to 28,500 million CNY by 2027, with a growth rate of 43.94% in 2024 [16]. - The radioactive co-mineral resource business is projected to see revenue growth from 1,164.08 million CNY in 2023 to 2,672.00 million CNY by 2027, with a notable increase of 39.51% in 2025 [16]. Industry Position - China Uranium Industry is a leading player in the uranium sector, with a strong historical presence and a comprehensive resource layout both domestically and internationally [19][24]. - The company controls significant uranium resources, ranking among the top ten global uranium producers, and has a robust operational footprint in key strategic areas [33][39]. Supply-Demand Dynamics - The global uranium market is characterized by a high concentration of resources, with the top five countries holding 68% of the total uranium reserves [39][40]. - The report highlights a persistent supply-demand gap in the uranium market, driven by increasing nuclear energy requirements and a recovery in global uranium production expected to reach 60,213 tons in 2024 [40][41].

Core Viewpoint - The company, China Uranium Corporation (001280.SZ), confirmed its involvement in thorium mining alongside uranium extraction, indicating a diversification in its resource utilization strategy [1] Group 1: Company Operations - The company currently engages in the comprehensive utilization of unique stone resources, which will lead to the production of chlorinated rare earths, uranium, and thorium products [1]

Core Viewpoint - China Uranium Industry (001280.SZ) emphasizes its role in the natural uranium business, which includes mining, sales, and trading, highlighting the importance of natural uranium in nuclear energy and defense sectors [1] Group 1: Natural Uranium Business - The company's natural uranium products include uranyl sulfate and uranium trioxide [1] - Natural uranium is a critical material for the development of nuclear energy, utilized in nuclear power and national defense [1] Group 2: Radioactive Co-Product Resource Utilization - The company engages in the comprehensive utilization of radioactive co-products, including monazite, uranium-molybdenum, tantalum, and niobium [1] - Key products from this business include rare earth chloride, ammonium molybdate, tantalum pentoxide, and niobium pentoxide [1] - Rare earth chloride serves as a primary raw material for rare earth oxides, while ammonium molybdate is an important intermediate product in deep processing of molybdenum, mainly used in steel, metallurgy, and chemical industries [1] - Tantalum pentoxide and niobium pentoxide are significant intermediate products in the deep processing of tantalum and niobium, applied across various sectors including steel, electronics, aerospace, medical, and superconductors [1]

Core Viewpoint - China Uranium Industry made a strong debut on the Shenzhen Stock Exchange, closing with a 280% increase, reflecting significant investor interest and confidence in the company's growth potential [1] Company Overview - China Uranium Industry submitted its IPO application in June 2024 and was among the first batch of companies accepted under the new "National Nine Articles" policy, successfully passing the review in September of the same year [1] - The company issued 248 million shares, raising 4.44 billion yuan, making it the third-largest fundraising IPO in A-shares for the year [1] - The net proceeds will primarily be used for the construction of four major uranium mining capacity projects and the comprehensive utilization of radioactive co-mined mineral resources [1] Business Operations - The company is engaged in the mining, sales, and trade of natural uranium resources, as well as the comprehensive utilization and sales of associated radioactive minerals [1] - Key products include natural uranium, rare earth chlorides, and ammonium molybdate, with a dominant position in the domestic uranium resource sector [1] - China Uranium Industry holds 19 mining rights and 6 exploration rights domestically and abroad, with its controlled Rosin Uranium Mine being the sixth-largest uranium mine globally and the second-largest open-pit uranium mine [1] Market Position and Demand - The global demand for natural uranium is expected to surge due to the revival of nuclear power, with the World Nuclear Association predicting a rise in global nuclear power capacity to 746 GWe by 2040, leading to a potential demand of nearly 204,600 tons of uranium [2] - The company has maintained a leading position in natural uranium production, sourcing uranium from both its own mines and international markets to supply domestic nuclear power plants [1][2] Financial Performance - The company's revenue has shown steady growth, with reported revenues of 14.801 billion yuan, 17.279 billion yuan, and 9.551 billion yuan for the years 2023 to the first half of 2025 [2] - Revenue from natural uranium business accounted for over 90% of total revenue during the same period, indicating a strong reliance on this segment [2] - Net profit attributable to shareholders was reported at 1.262 billion yuan, 1.458 billion yuan, and 765 million yuan for the same years [2] Shareholding Structure - China National Uranium Industry is the controlling shareholder of China Uranium Industry, holding 57.88% of the shares post-IPO, while the China National Nuclear Corporation indirectly controls 70.52% of the company [2]

Market Overview - The Shanghai Composite Index experienced narrow fluctuations around 3900 points, closing down 0.09% at 3894.22 points, while the Shenzhen Component Index and ChiNext Index fell by 0.19% and 0.5% respectively, with the Northbound 50 Index rising by 0.59% [1] - The total trading volume across the Shanghai, Shenzhen, and North exchanges reached 10,756 billion [1] Sector Performance - The real estate, semiconductor, and liquor sectors showed weakness, with over 3500 stocks declining [1] - The coal sector saw significant gains, with companies like Dayou Energy, Antai Group, and New Dazhou A hitting the daily limit, while Yunmei Energy rose approximately 6% [3][4] - The non-ferrous metals sector also performed well, with Huayang New Materials and Xinke Materials hitting the daily limit, and Tianshan Aluminum and Yun Aluminum rising over 5% [5] Diamond Industry - The cultivated diamond concept surged, with Sifangda rising nearly 15% and Huifeng Diamond increasing over 10% [7][8] - The diamond industry is focusing on functional applications, such as heat dissipation and optical window materials, which are expected to gain traction due to high demand from AI developments [9] China Uranium Industry - China Uranium (001280) debuted with a remarkable increase of 347%, reaching a peak of 80 yuan per share, and closed up 281.5% at 68.25 yuan per share, giving it a market capitalization exceeding 140 billion [11] - The company specializes in the comprehensive utilization of natural uranium and radioactive co-associated mineral resources, playing a crucial role in China's nuclear industry [11]

Core Viewpoint - China Uranium Corporation Limited ("China Uranium" or "parent company") has officially listed on the Shenzhen Stock Exchange on December 3, 2025, holding approximately 66.72% of the issued shares of China Nuclear International (02302) [1] Group 1: Company Overview - China Uranium's main business includes the mining, sales, and trading of natural uranium resources, as well as the comprehensive utilization and product sales of radioactive co-associated mineral resources such as monazite and uranium-molybdenum [1] - Key products of China Uranium include natural uranium, rare earth chlorides, and ammonium molybdate [1] Group 2: Strategic Implications - The successful listing of China Uranium is expected to enhance the company's capital market position and strengthen the synergy between the company and its parent [1] - The company anticipates benefiting from the increased influence of the parent company in the capital market, which will positively support brand recognition, resource integration, and strategic expansion [1]

Market Overview - The Shanghai Composite Index experienced narrow fluctuations around 3900 points, closing down 0.09% at 3894.22 points, while the Shenzhen Component Index and ChiNext Index fell by 0.19% and 0.5% respectively [1] - The total trading volume in the Shanghai, Shenzhen, and Beijing markets reached 10,756 billion [1] - Over 3500 stocks declined, with sectors like real estate, semiconductors, and liquor showing weakness, while the coal sector saw gains [1] Coal Sector Performance - The coal sector showed strong performance, with companies like Dayou Energy, Antai Group, and New Dazhou A hitting the daily limit [4][5] - The prices of thermal coal and coking coal remain at historical lows, providing room for a rebound due to supply-side policies and seasonal demand increases [6] Nonferrous Metals Sector - The nonferrous metals sector also strengthened, with companies like Huayang New Materials and Xinke Materials hitting the daily limit, and Tianshan Aluminum and Yun Aluminum rising over 5% [7] - Analysts predict that the nonferrous metals industry is entering a new upward cycle, driven by supply chain disruptions and liquidity easing from the Federal Reserve [7] Cultivated Diamonds Concept - The cultivated diamond concept saw significant gains, with companies like Sifangda and Huifeng Diamond rising nearly 15% and over 10% respectively [9][10] - The diamond industry is focusing on functional applications, with potential growth in chip manufacturing due to high heat dissipation demands [11] China Uranium Industry - China Uranium Industry debuted with a remarkable increase of 347%, reaching a peak of 80 yuan per share, and closing up 281.5% at 68.25 yuan per share, with a market capitalization exceeding 1400 billion [12][13] - The company specializes in the comprehensive utilization of natural uranium and radioactive co-associated mineral resources, playing a crucial role in China's nuclear supply chain [13]